Rhenman & Partners Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-40,000	Closed	-$6.12M	–	101
2021 Q1	$6.12M	Sell	40,000 -80,000	-67%	-$12.2M	0.43%	68
2020 Q4	$18.7M	Sell	120,000 -100,000	-45%	-$15.6M	1.53%	28
2020 Q3	$25.2M	Buy	220,000 +30,000	+16%	+$3.43M	2.24%	9
2020 Q2	$21.3M	Buy	190,000 +30,000	+19%	+$3.37M	2.3%	10
2020 Q1	$14.4M	Buy	160,000 +18,681	+13%	+$1.68M	2.01%	14
2019 Q4	$15.3M	Sell	141,319 -105,984	-43%	-$11.5M	1.67%	19
2019 Q3	$24.2M	Buy	247,303 +44,286	+22%	+$4.34M	3.04%	4
2019 Q2	$26.6M	Buy	203,017 +66,551	+49%	+$8.72M	2.93%	4
2019 Q1	$18.4M	Sell	136,466 -93,963	-41%	-$12.7M	2.16%	18
2018 Q4	$22.4M	Sell	230,429 -12,900	-5%	-$1.26M	2.56%	7
2018 Q3	$33.8M	Buy	243,329 +51,466	+27%	+$7.15M	3.39%	3
2018 Q2	$23.8M	Sell	191,863 -30,000	-14%	-$3.72M	2.44%	9
2018 Q1	$24.7M	Buy	221,863 +70,000	+46%	+$7.8M	3.05%	3
2017 Q4	$18.2M	Sell	151,863 -13,137	-8%	-$1.57M	2.45%	8
2017 Q3	$23.1M	Buy	165,000 +11,000	+7%	+$1.54M	2.96%	5
2017 Q2	$18.7M	Buy	154,000 +42,298	+38%	+$5.15M	2.69%	4
2017 Q1	$13.5M	Buy	111,702 +20,000	+22%	+$2.42M	2.14%	14
2016 Q4	$11.2M	Sell	91,702 -70,000	-43%	-$8.56M	2.15%	12
2016 Q3	$19.8M	Sell	161,702 -61,380	-28%	-$7.52M	3.15%	3
2016 Q2	$26M	Buy	223,082 +102,082	+84%	+$11.9M	4.63%	1
2016 Q1	$16.8M	Buy	121,000 +21,000	+21%	+$2.92M	3.34%	1
2015 Q4	$19.1M	Sell	100,000 -15,000	-13%	-$2.86M	2.88%	4
2015 Q3	$18M	Sell	115,000 -17,800	-13%	-$2.78M	2.87%	2
2015 Q2	$24M	Buy	132,800 +17,822	+16%	+$3.22M	2.88%	2
2015 Q1	$19.9M	Buy	114,978 +70,978	+161%	+$12.3M	3.36%	1
2014 Q4	$8.14M	Sell	44,000 -14,000	-24%	-$2.59M	2.36%	7
2014 Q3	$9.62M	Sell	58,000 -35,000	-38%	-$5.8M	2.82%	3
2014 Q2	$14.5M	Sell	93,000 -18,731	-17%	-$2.93M	4.31%	4
2014 Q1	$17M	Buy	111,731 +61,731	+123%	+$9.39M	5.1%	2
2013 Q4	$6.65M	Buy	+50,000	New	+$6.65M	2.6%	8